Infectious Mononucleosis

• CLINICAL_TRIALS trial_result · 2026-07-22
  Clinical Trial Results: Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults [Phase 1]

  Phase 1 trial evaluating safety and immunogenicity of an Epstein-Barr Virus gp350-Ferritin nanoparticle vaccine in healthy adults has comple…

• CLINICAL_TRIALS trial_result · 2026-04-22
  Clinical Trial Update: Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons [Phase 1, Phase 2]

  This trial update reports on the immunogenicity and safety of an adjuvanted Epstein-Barr virus glycoprotein 350 vaccine evaluated in EBV-ser…

• CLINICAL_TRIALS trial_result · 2025-07-17
  Clinical Trial Update: Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection [Phase 1]

  Phase 1 trial assessing safety and immunogenicity of an Epstein-Barr virus gp350-Ferritin nanoparticle vaccine in healthy adults with or wit…

• CLINICAL_TRIALS trial_result · 2022-07-11
  Clinical Trial Update: Acupuncture for Infectious Mononucleosis Trial [Phase 2, Phase 3]

  A clinical trial update indicates termination of a study evaluating acupuncture for infectious mononucleosis in Phase 2 and Phase 3.

• CLINICAL_TRIALS trial_result · 2015-03-17
  Clinical Trial Update: Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection [Phase 1, Phase 2]

  Phase 1/Phase 2 trial of valomaciclovir for infectious mononucleosis due to primary Epstein-Barr virus infection; results were posted in 201…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2011-10-27
  Clinical Trial Update: Controlled Trial of Valacyclovir in Infectious Mononucleosis [Phase 1, Phase 2]

  A completed Phase 1/2 controlled trial evaluating valacyclovir in infectious mononucleosis.